Internal Medicine, Gastroenterology · Tampa, FL
NPI
1053403923
Since 2006
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
14547 Bruce B. Downs Blvd.
Tampa, FL, 33613
Phone (813) 280-7100
Groups this clinician bills Medicare through
Medicare paid, 2024
$79K
844 services
Medicare patients, 2024
401
Average age 73
Drug cost, 2024
$1.0M
2,908 prescriptions
Company payments, 2025
$1,536
From 16 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Martin E Maldonado-Alfandari was code 99214 (office e&m - established), 278 times for 207 patients. In total Martin E Maldonado-Alfandari billed 844 services in 21 codes, and Medicare paid $79K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-05-23.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 278 | 207 | $85.45 | $24K |
| 99213 Office E&M - Established | Office | 192 | 160 | $61.69 | $12K |
| 45385 Colonoscopy - Lesion Removal | Facility | 83 | 82 | $202.25 | $17K |
| 43239 Upper GI Endoscopy | Facility | 79 | 77 | $45.83 | $3,620 |
| 99204 Office E&M - New | Office | 43 | 43 | $109.31 | $4,700 |
| G0105 Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 32 | 32 | $171.84 | $5,499 |
| 45380 Lower GI Endoscopy - Other | Facility | 26 | 26 | $72.64 | $1,889 |
| 43248 Upper GI Endoscopy | Facility | 21 | 19 | $105.29 | $2,211 |
| 43251 Upper GI Endoscopy | Facility | 16 | 16 | $129.37 | $2,070 |
| 99203 Office E&M - New | Office | 12 | 12 | $69.83 | $838 |
| 45378 Lower GI Endoscopy - Other | Facility | 12 | 12 | $129.33 | $1,552 |
| G0121 Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 11 | 11 | $172.69 | $1,900 |
By year: 2022 $94K for 989 services; 2023 $96K for 972 services; 2024 $79K for 844 services.
Medicare prescription drug claims, 2024
In 2024, the drug Martin E Maldonado-Alfandari prescribed most often to Medicare patients was Pantoprazole Sodium, with 1,131 prescriptions and refills. In total Martin E Maldonado-Alfandari wrote 2,908 Medicare prescriptions that cost $1.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Pantoprazole Sodium Generic | 1,131 | 3,258 | 417 | $13K |
| Famotidine Generic | 225 | 650 | 92 | $4,751 |
| Dicyclomine Hcl Generic | 173 | 419 | 78 | $5,957 |
| Omeprazole Generic | 152 | 403 | 66 | $2,061 |
| Sucralfate Generic | 110 | 215 | 39 | $7,665 |
| Linzess Linaclotide | 99 | 240 | 39 | $127K |
| Creon Lipase/Protease/Amylase | 99 | 198 | 33 | $454K |
| Mirtazapine Generic | 88 | 237 | 33 | $1,562 |
| Rabeprazole Sodium Generic | 84 | 231 | 35 | $4,299 |
| Ondansetron Odt Ondansetron | 78 | 84 | 42 | $1,636 |
| Esomeprazole Magnesium Generic | 59 | 175 | 27 | $2,357 |
| Dexlansoprazole Dr Dexlansoprazole | 52 | 112 | 21 | $15K |
| Lubiprostone Generic | 45 | 97 | 26 | $6,769 |
| Metoclopramide Hcl Generic | 41 | 77 | 21 | $265 |
| Xifaxan Rifaximin | 41 | 41 | Under 11 | $134K |
Brand drugs: - claims; generic drugs: 2,515 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Martin E Maldonado-Alfandari $1,536 ($1,536 in general payments such as food, travel and fees) from 16 companies. The largest payer was Abbvie Inc. with $643.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 33 | $643 |
| Genzyme Corporation SNY | 6 | $177 |
| Gilead Sciences, Inc. GILD | 8 | $138 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 4 | $115 |
| Aimmune Therapeutics, Inc. | 4 | $83.6 |
| Pfizer Inc. PFE | 4 | $75.72 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 3 | $57.78 |
| Boston Scientific Corporation BSX | 1 | $56.11 |
| Lilly USA, LLC LLY | 2 | $44.06 |
| Ipsen Biopharmaceuticals, Inc IPN.PA | 1 | $25.95 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.